Suppr超能文献

印度高血压患者中高敏C反应蛋白的患病率。

Prevalence of hs-CRP among Indians with hypertension.

作者信息

R Vasanthii, G Kaarthikeyan, G Sasirekha, S Mahalakshmi

机构信息

Department of Biochemistry, Madurai Medical College,GRH, Madurai,India.

Saveetha Dental College & Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai - 77, India.

出版信息

Bioinformation. 2022 Oct 31;18(10):1041-1043. doi: 10.6026/973206300181041. eCollection 2022.

Abstract

The prevalence of hypertension in the early twentieth century varied in India, ranging from 2-15% in Urban India and 2-8% in Rural India. In the inter heart and inter stroke study, hypertension accounted for 17.9% and 34.6% of population attributable risk for coronary artery disease and stroke respectively. CRP appears in serum in response to a variety of inflammatory stimuli .Raised level of hs-CRP is seen with increasing with age, during an infection, inflammation, coronary artery diseases, obesity, sepsis, smoking and vasculitis. CRP is also a factor in the development of atherosclerotic plaque. Although CRP was believed to be a marker of vascular inflammation, recent research indicates that it plays an active role in atherogenesis. So in this study we measured serum hs- CRP in patients with essential hypertension and correlated with blood pressure. The study consists of 50 patients with essential hypertension with antihypertensive medications. in the age group of 40 to 60 years of both sexes and 25 normotensive subjects with no history of cardiovascular, neoplastic, hepatic, renal, infectious or auto immune disease. IHEC clearance and informed consent were obtained. hs-CRP was measured by ELISA kit. Our study showed significantly elevated serum hs-CRP level in hypertensive subjects in comparison with control subjects. To find out the relationship between physiological and biochemical parameters with CRP Pearson correlation coefficient has been applied. The level of significance has been fixed as 5% (p<0.05). SPSS15 software has been used for calculation. Our study showed significantly elevated serum hs-CRP level in hypertensive subjects in comparison with control subjects. But there is no correlation of hs-CRP level with both systolic and diastolic pressure. Several studies have shown inflammatory markers such as CRP as an independent determinant of endothelium dependent vascular function among patient with coronary heart disease (CHD) in patients with hypertension. There was no significant correlation was observed between levels of hs-CRP and systolic and diastolic blood pressure in this study but there was a significant elevation hs-CRP level was observed in hypertensive patients.

摘要

20世纪初,印度高血压患病率各不相同,印度城市地区为2%-15%,农村地区为2%-8%。在“心脏与中风国际研究”中,高血压分别占冠状动脉疾病和中风人群归因风险的17.9%和34.6%。CRP在血清中出现是对多种炎症刺激的反应。随着年龄增长、感染、炎症、冠状动脉疾病、肥胖、脓毒症、吸烟和血管炎,hs-CRP水平会升高。CRP也是动脉粥样硬化斑块形成的一个因素。尽管CRP曾被认为是血管炎症的标志物,但最近的研究表明它在动脉粥样硬化形成中起积极作用。因此,在本研究中,我们测量了原发性高血压患者的血清hs-CRP,并将其与血压进行关联。该研究包括50例服用抗高血压药物的原发性高血压患者,年龄在40至60岁之间,男女皆有,以及25例无心血管、肿瘤、肝脏、肾脏、感染或自身免疫疾病史的血压正常受试者。获得了伦理委员会批准和知情同意。hs-CRP通过ELISA试剂盒进行测量。我们的研究表明,与对照组相比,高血压受试者的血清hs-CRP水平显著升高。为了找出生理和生化参数与CRP之间的关系,应用了Pearson相关系数。显著性水平设定为5%(p<0.05)。使用SPSS15软件进行计算。我们的研究表明,与对照组相比,高血压受试者的血清hs-CRP水平显著升高。但hs-CRP水平与收缩压和舒张压均无相关性。多项研究表明,在高血压患者的冠心病(CHD)患者中,诸如CRP等炎症标志物是内皮依赖性血管功能的独立决定因素。在本研究中,未观察到hs-CRP水平与收缩压和舒张压之间存在显著相关性,但在高血压患者中观察到hs-CRP水平显著升高。

相似文献

1
Prevalence of hs-CRP among Indians with hypertension.印度高血压患者中高敏C反应蛋白的患病率。
Bioinformation. 2022 Oct 31;18(10):1041-1043. doi: 10.6026/973206300181041. eCollection 2022.

本文引用的文献

2
Is hypertension an inflammatory process?高血压是一种炎症过程吗?
Curr Pharm Des. 2006;12(13):1623-35. doi: 10.2174/138161206776843313.
4
C-reactive protein and the risk of developing hypertension.C反应蛋白与患高血压的风险
JAMA. 2003 Dec 10;290(22):2945-51. doi: 10.1001/jama.290.22.2945.
9
Determinants of femoral and carotid artery atherosclerosis.股动脉和颈动脉粥样硬化的决定因素。
J Intern Med. 1994 Jul;236(1):79-84. doi: 10.1111/j.1365-2796.1994.tb01123.x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验